<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ab binding to CD20 has been shown to induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in B cells </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we demonstrate that rituximab sensitizes <z:hpo ids='HP_0002665'>lymphoma</z:hpo> B cells to Fas-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in a caspase-8-dependent manner </plain></SENT>
<SENT sid="2" pm="."><plain>To elucidate the mechanism by which Rituximab affects Fas-mediated cell <z:hpo ids='HP_0011420'>death</z:hpo>, we investigated rituximab-induced signaling and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> pathways </plain></SENT>
<SENT sid="3" pm="."><plain>Rituximab-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> involved the <z:hpo ids='HP_0011420'>death</z:hpo> receptor pathway and proceeded in a caspase-8-dependent manner </plain></SENT>
<SENT sid="4" pm="."><plain>Ectopic overexpression of FLIP (the physiological inhibitor of the <z:hpo ids='HP_0011420'>death</z:hpo> receptor pathway) or application of zIETD-fmk (specific inhibitor of caspase-8, the initiator-caspase of the <z:hpo ids='HP_0011420'>death</z:hpo> receptor pathway) both specifically reduced rituximab-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in Ramos B cells </plain></SENT>
<SENT sid="5" pm="."><plain>Blocking the <z:hpo ids='HP_0011420'>death</z:hpo> receptor ligands Fas ligand or TRAIL, using neutralizing Abs, did not inhibit <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, implying that a direct <z:hpo ids='HP_0011420'>death</z:hpo> receptor/ligand interaction is not involved in CD20-mediated cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Instead, we hypothesized that rituximab-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> involves membrane clustering of Fas molecules that leads to formation of the <z:hpo ids='HP_0011420'>death</z:hpo>-inducing signaling complex (DISC) and downstream activation of the <z:hpo ids='HP_0011420'>death</z:hpo> receptor pathway </plain></SENT>
<SENT sid="7" pm="."><plain>Indeed, Fas coimmune precipitation experiments showed that, upon CD20-cross-linking, Fas-associated <z:hpo ids='HP_0011420'>death</z:hpo> domain protein (FADD) and caspase-8 were recruited into the DISC </plain></SENT>
<SENT sid="8" pm="."><plain>Additionally, rituximab induced CD20 and Fas translocation to raft-like domains on the cell surface </plain></SENT>
<SENT sid="9" pm="."><plain>Further analysis revealed that, upon stimulation with rituximab, Fas, caspase-8, and FADD were found in <z:chebi fb="27" ids="17992">sucrose</z:chebi>-gradient raft fractions together with CD20 </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, in this study, we present evidence for the involvement of the <z:hpo ids='HP_0011420'>death</z:hpo> receptor pathway in rituximab-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of Ramos B cells with concomitant sensitization of these cells to Fas-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> via Fas multimerization and recruitment of caspase-8 and FADD to the DISC </plain></SENT>
</text></document>